豚流行性下痢ワクチンの世界市場レポート 2025年

豚流行性下痢ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.6％で24億2,000万米ドルに成長します。予測期間の成長は、予防接種プログラムの重視、ワクチン開発パイプラインの拡大、豚の個体数拡大、コールドチェーン管理の重視、予防ヘルスケア対策の重要性に対する意識の高まりに起因しています。予測期間における主な動向としては、ワクチン送達デバイス技術の継続的な革新、針を使わないソリューションへの注目、個別化医療の進歩、自己投与ワクチンへの嗜好の高まり、動物ヘルスケアインフラと流通網の強化などが挙げられます。

豚流行性下痢（PED）ワクチン市場の成長は、養豚産業の成長によって牽引されると予想されます。養豚業には、食肉生産用の家畜豚の飼育、繁殖、飼育、出生から市場体重までの管理、豚肉製品のマーケティングと販売が含まれます。養豚業の拡大には、豚肉に対する世界の需要の増加、繁殖・管理方法の改善、農業技術の進歩、豚肉消費市場の拡大が寄与しています。PEDワクチンは、養豚におけるアウトブレイクの予防と管理において重要な役割を果たしています。これらのワクチンは通常、母豚の妊娠期間中から注射または経口投与され、初乳を介して生まれたばかりの子豚に受動免疫を与えます。例えば、米国農務省の報告によると、2022年の米国における豚肉生産量は406億ポンドに達し、前年比1％増となりました。その結果、養豚業の成長は豚流行性下痢ワクチンの需要を促進する重要な要因となっています。

豚流行性下痢ワクチン分野の主要企業は、市場での地位を強化するために技術革新に注力しています。注目すべき開発のひとつは、豚パルボウイルス（PPV）ワクチンの導入で、PPVによる豚の繁殖不全を予防するために設計されています。ベーリンガーインゲルハイムは2022年3月にReproCyc ParvoFLEXワクチンを発売し、PPVに起因する不妊症、死産、ミイラ化胎児、虚弱子豚に対する包括的な保護を提供しました。この革新的なワクチンは、高度な製剤と有効性により豚群の健康と生産性を向上させるという同社のコミットメントを強調するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界豚流行性下痢ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の豚流行性下痢ワクチン市場：成長率分析
• 世界の豚流行性下痢ワクチン市場の実績：規模と成長, 2019-2024
• 世界の豚流行性下痢ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界豚流行性下痢ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の豚流行性下痢ワクチン市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生ワクチン
• 不活化ワクチン
• 世界の豚流行性下痢ワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 子豚
• 成豚
• 世界の豚流行性下痢ワクチン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院
• 養豚農場
• 世界の豚流行性下痢ワクチン市場生ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口生ワクチン
• 注射用生ワクチン
• 世界の豚流行性下痢ワクチン市場不活化ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化注射ワクチン
• 不活化経口ワクチン

第7章 地域別・国別分析

• 世界の豚流行性下痢ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の豚流行性下痢ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 豚流行性下痢ワクチン市場：競合情勢
• 豚流行性下痢ワクチン市場：企業プロファイル
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • Idexx Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ceva Sante Animale Health Company
• Phibro Animal Health Corporation
• Benchmark Animal Health Ltd.
• IDT Biologika GmbH
• Vaxxinova
• Qilu Animal Health Products Factory Co. Ltd.
• Tecnovax
• Green Cross Veterinary Products Co. Ltd.
• Nisseiken Co. Ltd.
• Komipharm International Co. Ltd.
• Boehringer Ingelheim Animal Health
• MSD Animal Health
• Ourofino Saude Animal
• Medgene Labs
• Harrisvaccines Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 豚流行性下痢ワクチン市場2029：新たな機会を提供する国
• 豚流行性下痢ワクチン市場2029：新たな機会を提供するセグメント
• 豚流行性下痢ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Porcine epidemic diarrhea (PED) vaccines are formulated to confer immunity against the porcine epidemic diarrhea virus (PEDV), which causes severe gastrointestinal illness in pigs. These vaccines play a crucial role in preventing and managing outbreaks of Porcine Epidemic Diarrhea, thereby safeguarding the health and productivity of pig populations and ensuring the economic stability of the swine industry.

The primary types of porcine epidemic diarrhea vaccines are live vaccines and killed vaccines. Live vaccines contain attenuated or weakened forms of the PEDV virus. They are utilized in diverse settings, including piglets and adult pigs, across veterinary hospitals and hog production farms.

The porcine epidemic diarrhea vaccines market research report is one of a series of new reports from The Business Research Company that provides porcine epidemic diarrhea vaccines market statistics, including porcine epidemic diarrhea vaccines industry global market size, regional shares, competitors with a porcine epidemic diarrhea vaccines market share, detailed porcine epidemic diarrhea vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the porcine epidemic diarrhea vaccines industry. This porcine epidemic diarrhea vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The porcine epidemic diarrhea vaccines market size has grown strongly in recent years. It will grow from $1.67 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to large-scale vaccination campaigns, expanded programs on immunization (EPI), the adoption of disposable syringes, diarrhea eradication efforts, and initiatives like the global alliance for vaccines and immunization (GAVI).

The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pig populations, focus on cold chain management, and rising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, growing preference for self-administered vaccines, and strengthening animal healthcare infrastructure and distribution networks.

The growth of the porcine epidemic diarrhea (PED) vaccine market is expected to be driven by the rising pig farming industry. Pig farming encompasses the raising of domestic pigs for meat production, breeding, rearing, managing them from birth to market weight, and marketing and selling pork products. The expansion of pig farming is fueled by the growing global demand for pork, improvements in breeding and management practices, advancements in farming technology, and the expanding markets for pork consumption. PED vaccines play a crucial role in preventing and managing outbreaks in pig farming. These vaccines are typically administered through injection or orally, starting during the sow's gestation period, to provide passive immunity to newborn piglets via colostrum. For example, the United States Department of Agriculture reported that in 2022, pork production in the U.S. reached 40.6 billion pounds, marking a 1 percent increase compared to the previous year. Consequently, the growth of pig farming is a key factor driving the demand for porcine epidemic diarrhea vaccines.

Leading companies in the porcine epidemic diarrhea vaccines sector are focusing on innovation to strengthen their market positions. One notable development is the introduction of the porcine parvovirus (PPV) vaccine, designed to prevent reproductive failures in pigs caused by PPV. Boehringer Ingelheim launched the ReproCyc ParvoFLEX vaccine in March 2022, which offers comprehensive protection against infertility, stillbirths, mummified fetuses, and weak piglets resulting from PPV. This innovative vaccine underscores the company's commitment to enhancing the health and productivity of pig herds through advanced formulation and efficacy.

In November 2024, Phibro Animal Health Corporation, a US-based health company, acquired Zoetis Inc. for an undisclosed amount. This acquisition is intended to expand Phibro's product offerings in medicated feed additives and water-soluble products for cattle, swine, and poultry, enhancing its ability to support global animal health and nutrition. Additionally, the acquisition aims to boost Phibro's profitability, grow its revenue base, and provide capital for future investments in the animal health sector. Zoetis Inc. is a pharmaceutical manufacturer specializing in the production of vaccines for porcine epidemic diarrhea.

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Sante Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saude Animal, Medgene Labs, Harrisvaccines Inc

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the porcine epidemic diarrhea vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The porcine epidemic diarrhea vaccines market consists of sales of ingelvac PEDV, barricade, PED vax, PEDV shield, and enterisol ileitis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Porcine Epidemic Diarrhea Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on porcine epidemic diarrhea vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for porcine epidemic diarrhea vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The porcine epidemic diarrhea vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Live Vaccines; Killed Vaccines
• 2) By Application: Piglets; Adults Pigs
• 3) By End-User: Veterinary Hospitals; Hog Production Farms
• Subsegments:
• 1) By Live Vaccines: Oral Live Vaccines; Injectable Live Vaccines
• 2) By Killed Vaccines: Inactivated Injectable Vaccines; Inactivated Oral Vaccines
• Companies Mentioned: Zoetis Inc.; Merck Animal Health; Elanco Animal Health; Idexx Laboratories Inc.; Bio-Rad Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Porcine Epidemic Diarrhea Vaccines Market Characteristics

3. Porcine Epidemic Diarrhea Vaccines Market Trends And Strategies

4. Porcine Epidemic Diarrhea Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Porcine Epidemic Diarrhea Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Porcine Epidemic Diarrhea Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Porcine Epidemic Diarrhea Vaccines Market Growth Rate Analysis
• 5.4. Global Porcine Epidemic Diarrhea Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Porcine Epidemic Diarrhea Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Porcine Epidemic Diarrhea Vaccines Total Addressable Market (TAM)

6. Porcine Epidemic Diarrhea Vaccines Market Segmentation

• 6.1. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Vaccines
• Killed Vaccines
• 6.2. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Piglets
• Adults Pigs
• 6.3. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Hog Production Farms
• 6.4. Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Live Vaccines
• Injectable Live Vaccines
• 6.5. Global Porcine Epidemic Diarrhea Vaccines Market, Sub-Segmentation Of Killed Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Injectable Vaccines
• Inactivated Oral Vaccines

7. Porcine Epidemic Diarrhea Vaccines Market Regional And Country Analysis

• 7.1. Global Porcine Epidemic Diarrhea Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Porcine Epidemic Diarrhea Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market

• 8.1. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Porcine Epidemic Diarrhea Vaccines Market

• 9.1. China Porcine Epidemic Diarrhea Vaccines Market Overview
• 9.2. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Porcine Epidemic Diarrhea Vaccines Market

• 10.1. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Porcine Epidemic Diarrhea Vaccines Market

• 11.1. Japan Porcine Epidemic Diarrhea Vaccines Market Overview
• 11.2. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Porcine Epidemic Diarrhea Vaccines Market

• 12.1. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Porcine Epidemic Diarrhea Vaccines Market

• 13.1. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Porcine Epidemic Diarrhea Vaccines Market

• 14.1. South Korea Porcine Epidemic Diarrhea Vaccines Market Overview
• 14.2. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Porcine Epidemic Diarrhea Vaccines Market

• 15.1. Western Europe Porcine Epidemic Diarrhea Vaccines Market Overview
• 15.2. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Porcine Epidemic Diarrhea Vaccines Market

• 16.1. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Porcine Epidemic Diarrhea Vaccines Market

• 17.1. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Porcine Epidemic Diarrhea Vaccines Market

• 18.1. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Porcine Epidemic Diarrhea Vaccines Market

• 19.1. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Porcine Epidemic Diarrhea Vaccines Market

• 20.1. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market

• 21.1. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market Overview
• 21.2. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Porcine Epidemic Diarrhea Vaccines Market

• 22.1. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Porcine Epidemic Diarrhea Vaccines Market

• 23.1. North America Porcine Epidemic Diarrhea Vaccines Market Overview
• 23.2. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Porcine Epidemic Diarrhea Vaccines Market

• 24.1. USA Porcine Epidemic Diarrhea Vaccines Market Overview
• 24.2. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Porcine Epidemic Diarrhea Vaccines Market

• 25.1. Canada Porcine Epidemic Diarrhea Vaccines Market Overview
• 25.2. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Porcine Epidemic Diarrhea Vaccines Market

• 26.1. South America Porcine Epidemic Diarrhea Vaccines Market Overview
• 26.2. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Porcine Epidemic Diarrhea Vaccines Market

• 27.1. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Porcine Epidemic Diarrhea Vaccines Market

• 28.1. Middle East Porcine Epidemic Diarrhea Vaccines Market Overview
• 28.2. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Porcine Epidemic Diarrhea Vaccines Market

• 29.1. Africa Porcine Epidemic Diarrhea Vaccines Market Overview
• 29.2. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Porcine Epidemic Diarrhea Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Porcine Epidemic Diarrhea Vaccines Market Competitive Landscape
• 30.2. Porcine Epidemic Diarrhea Vaccines Market Company Profiles
  • 30.2.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Elanco Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Idexx Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Porcine Epidemic Diarrhea Vaccines Market Other Major And Innovative Companies

• 31.1. Ceva Sante Animale Health Company
• 31.2. Phibro Animal Health Corporation
• 31.3. Benchmark Animal Health Ltd.
• 31.4. IDT Biologika GmbH
• 31.5. Vaxxinova
• 31.6. Qilu Animal Health Products Factory Co. Ltd.
• 31.7. Tecnovax
• 31.8. Green Cross Veterinary Products Co. Ltd.
• 31.9. Nisseiken Co. Ltd.
• 31.10. Komipharm International Co. Ltd.
• 31.11. Boehringer Ingelheim Animal Health
• 31.12. MSD Animal Health
• 31.13. Ourofino Saude Animal
• 31.14. Medgene Labs
• 31.15. Harrisvaccines Inc

32. Global Porcine Epidemic Diarrhea Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Porcine Epidemic Diarrhea Vaccines Market

34. Recent Developments In The Porcine Epidemic Diarrhea Vaccines Market

35. Porcine Epidemic Diarrhea Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Porcine Epidemic Diarrhea Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Porcine Epidemic Diarrhea Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Porcine Epidemic Diarrhea Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer